New Jersey S 1102: Establishes limitations on and conditions associated with prescribers' acceptance of compensation from pharmaceutical manufacturers.

Status: Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee (as of 2022-01-31)

State: New Jersey · Session: 220 · Bill: S 1102

Subjects: PHARMACEUTIC

Sponsors: Vitale, Joseph F.

View New Jersey S 1102 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.